Interleukin-6 (IL-6) is a pleiotropic cytokine that plays an important role in the megakaryocytic differentiation. Recently, we have observed that IL-6 is synthesized by several human cell lines with megakaryocytic features. In this study, we have investigated whether a similar phenomenon occurs during normal megakaryocytic differentiation. Human megakaryocytes (MK) were obtained by culturing normal marrow in liquid culture with aplastic plasma (AP). First, an IL-6 secretion in bone marrow culture enriched in MK as well as in purified MK populations was demonstrated by a biologic assay. Second, IL-6 mRNA was detected in a purified population of MK by the polymerase chain reaction and dot blot analysis. IL-6 mRNA and protein were undetectable in platelets. Third, in situ hybridization procedure demonstrated the presence of IL-6 mRNA in individual immature MK. Fourth, IL-6 protein was detected in MK at the unicellular level by an UMAN megakaryocytopoiesis is a complex phenome-H non that includes proliferation of committed megakaryocytic progenitor cells, nuclear polyploidization, growth in size, and generation of cytoplasmic lineage markers. This process leads to platelet production and is highly regulated by several proliferation and/or maturation growth molecules. ' Numerous studies suggest that this regulation takes place at both an early and a late stage of differentiation. In early steps of differentiation, several growth factors, such as interleukin-3 (IL-3) and granulocyte-macrophage colonystimulating factor (GM-CSF), are able to induce proliferation and differentiation of the committed progenitors, but none of these factors has been shown to be specific for the megakaryocyte (MK) lineage. In contrast, it was believed until recently that late stages, including polyploidization and maturation, were under the control of specific factor(s) called thrombopoietin,2 MK stimulatory factor; or thrombopoiesis stimulatory factor: However, more recently it has been shown that IL-3 and possibly GM-CSF may also interact with late stages of differentiation. Surprisingly, numerous recent data show that IL-6, a cytokine with pleiotropic effects on hematopoietic cells, on B and T lymphocytes, and on nonhematopoietic cells,5 is one of the main regulators of the murine late MK stages. In vitro, IL-6 increases ploidization, size, and acetylcholinesterase activity of individual MK6; in vivo injection of IL-6 significantly increases platelet production' and transgenic mice carrying human IL-6 have an increased number of MK in the marrow. ' Recently, we have investigated synthesis of IL-6 and IL-6 receptors (IL-6-R) in several human leukemic cell lines and found that IL-6 and IL-6-R could be constitutively expressed in cell lines with erythroid/MK features.' Therefore, we investigated whether this phenomenon was associated with leukemic transformation or might occur during normal megakaryocytopoiesis.
Interleukin-6 (IL-6) is a pleiotropic cytokine that plays an important role in the megakaryocytic differentiation. Recently, we have observed that IL-6 is synthesized by several human cell lines with megakaryocytic features. In this study, we have investigated whether a similar phenomenon occurs during normal megakaryocytic differentiation. Human megakaryocytes (MK) were obtained by culturing normal marrow in liquid culture with aplastic plasma (AP). First, an IL-6 secretion in bone marrow culture enriched in MK as well as in purified MK populations was demonstrated by a biologic assay. Second, IL-6 mRNA was detected in a purified population of MK by the polymerase chain reaction and dot blot analysis. IL-6 mRNA and protein were undetectable in platelets. Third, in situ hybridization procedure demonstrated the presence of IL-6 mRNA in individual immature MK. Fourth, IL-6 protein was detected in MK at the unicellular level by an UMAN megakaryocytopoiesis is a complex phenome-H non that includes proliferation of committed megakaryocytic progenitor cells, nuclear polyploidization, growth in size, and generation of cytoplasmic lineage markers. This process leads to platelet production and is highly regulated by several proliferation and/or maturation growth molecules. ' Numerous studies suggest that this regulation takes place at both an early and a late stage of differentiation. In early steps of differentiation, several growth factors, such as interleukin-3 (IL-3) and granulocyte-macrophage colonystimulating factor (GM-CSF), are able to induce proliferation and differentiation of the committed progenitors, but none of these factors has been shown to be specific for the megakaryocyte (MK) lineage. In contrast, it was believed until recently that late stages, including polyploidization and maturation, were under the control of specific factor(s) called thrombopoietin,2 MK stimulatory factor; or thrombopoiesis stimulatory factor: However, more recently it has been shown that IL-3 and possibly GM-CSF may also interact with late stages of differentiation. Surprisingly, numerous recent data show that IL-6, a cytokine with pleiotropic effects on hematopoietic cells, on B and T lymphocytes, and on nonhematopoietic cells,5 is one of the main regulators of the murine late MK stages. In vitro, IL-6 increases ploidization, size, and acetylcholinesterase activity of individual MK6; in vivo injection of IL-6 significantly increases platelet production' and transgenic mice carrying human IL-6 have an increased number of MK in the marrow. ' Recently, we have investigated synthesis of IL-6 and IL-6 receptors (IL-6-R) in several human leukemic cell lines and found that IL-6 and IL-6-R could be constitutively expressed in cell lines with erythroid/MK features.' Therefore, we investigated whether this phenomenon was associated with leukemic transformation or might occur during normal megakaryocytopoiesis.
immunoalkaline phosphatase technique using a monoclonal antibody against IL-6. Furthermore, the presence of IL-6 receptor (IL-6-R) on MK was demonstrated by in situ hybridization using an IL-6-R probe and in situ autoradiography after binding with ['nl]-labeled recombinant IL-6. The IL-6 endogenously produced in liquid cultures containing normal human plasma or AP was subsequently neutralized. This resulted in a 50% decrease of the MK growth with a minor shift in the ploidy distribution toward lower values. In semisolid cultures the addition of anti-ll-6 antibodies led to a 42% decrease in colony number in cultures stimulated by IL-3 but not in other conditions of culture. These results suggest that normal human megakaryocytopoiesis might be regulated in part by an IL-6 autocrine loop.
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MATERIALS AND METHODS

Cell samples and cell lines.
Bone marrow aspirates were obtained from normal adult donors for bone marrow transplantation after informed consent. They were collected into sterile syringes containing preservative-free heparin (50 ,UlmL; Roche, Paris, France). All samples were obtained in accordance with institutional guidelines of the Committee on Human Investigation. Low-density cells were separated by velocity centrifugation on Ficoll-metrizoate gradient (density 1.077 g/mL; Biochrom KG, Berlin, Germany) and were washed three times in a-medium (Eurobio, Paris, France) containing penicillinlstreptomycin (Boehringer, Mannheim, Germany) and glutamine (Eurobio). Adherent cell depletion was performed by incubation of the cell suspension (1 x lo6 per mL) in a-medium with 10% (volhrol) fetal calf serum (Boehringer) for at least 1 hour on plastic culture Petri dishes (Corning Glass Works, Corning, NY). Nonadherent cells were recovered and used for cell cultures in liquid medium or in semisolid assays.
Human normal mononuclear blood cells were obtained by Ficoll separation as described above from fresh platelet residue bags provided by the Centre DCpartemental de transfusion du Val de Marne (CrCteil, France); these preparations were enriched in 462 NAVARRO ET AL monocytes. Monocytes were separated from lymphocytes by a 2-hour adherence and used for RNA extraction.
Human platelets were isolated from healthy adult donors by differential centrifugation of whole blood collected into acid-citratedextrose anticoagulant. Leukocyte contaminant was removed by filtration (Pall, East Hills, NY) and washed purified platelets were used for RNA and protein extractions, IL-6 bioassay, and enzymelinked immunosorbent assay (ELISA). The purity of platelets was assessed by an indirect immunofluorescence procedure using monoclonal antibodies (MoAbs) directed against antigens of the B-cell, T-cell, and monocyte lineages. No contaminant leukocytes were detected in these purified platelet preparations.
Several cell lines were used as positive and negative controls for the presence of IL-6 and IL-6-R,9 ie, the monoblastic cell line U937'' and the erythroid or megakaryocytic cell lines K.562," HELVJ2O (a subclone of HEL)," and MEG-01.I3 All cell lines were grown in culture flasks at 37°C in RPMI 1640 (Boehringer) containing 10% (volhrol) fetal calf serum (Boehringer) in a fully humidified atmosphere with 5% CO,.
As described previo~sly,'~ bone marrow lowdensity cells (density < 1.077 g/mL) were cultured in liquid medium at a concentration of lo6 cells/mL to obtain large numbers of MK differentiating from colony-forming unit MK (CFU-MK). Briefly, Iscove's modified Dulbecco's medium (GIBCO, Paisley, Scotland) was supplemented with 1% deionized bovine serum albumin (Cohn fraction V; Sigma, St Louis, MO) and 10% plasma from patients with aplastic marrows (AF') (thrombocytopenic patients after a bone marrow transplantation) or serum derived from platelet-poor plasma (PPP) of normal donors.15 Cell cultures were performed for 10 to 14 days in 25-cm2 or 75-cm2 tissue culture flasks (Corning Glass Works) at 37°C in a 5% CO, fully humidified atmosphere. From day 5 of culture, flasks were changed daily to enhance the proportion of MK by removing adherent macrophages. In this condition of culture, the predominant contaminant cell population was macrophages, and some granulocytic precursors were also present.
Cells were processed for: (1) MKpurification by the immunomagnetic bead technique at day 10 of culture or by cell sorting at day 6 of culture; (2) in situ hybridization, in situ autoradiography, and immunocytochemical staining at day 10 to 13 of culture, and (3) for flow cytometry analysis at day 10 or 11 of culture.
Bone marrow low-density cells were also cultured in a semisolid medium using the plasma clot technique as previously described for the CFU-MK assay." The medium contains a-medium, 1% deionized bovine serum albumin, 20 p g h L asparagine, 28 kg/mL CaCI,, 10% of either serum derived from AP (AS) or PPP plus recombinant human IL-3 (rhIL-3) (100 U/mL; Genetics Institute, Cambridge, MA), and 2.5 x 105 nonadherent bone marrow cells. Citrated bovine plasma (GIBCO) (10%) was added as the last product. AS, PPP, and citrated bovine plasma used in these cultures were devoid of any detectable IL-6 activity. Culture medium in 1-mL increments was pipetted into 35-mm Petri dishes and allowed to clot. Cultures were incubated for 12 days at 37°C in duplicate. Quantitation of colonies was performed by an indirect immunofluorescent labeling as previously described" using an MoAb against glycoprotein (GP) IIIa (Y2/51).I6 Each dish was entirely scanned under a fluorescent microscope at a 100 x magnification at day 12 of culture, and each cluster of three or more MK were scored as a colony.
Cultured human MK were purified by a two-layer immunomagnetic bead technique." The first antibody was an anti-GP IIIa antibody (C17 or Y2/51)16 and the second layer was goat antimouse IgG coupled to magnetic beads (Dynabeads M-450; Dynal AS, Oslo, Norway). After purification, cells were labeled by a polyclonal antibody against von Willebrand factor and MK cultures.
Purification of MK.
more than 96% of the cells were stained. Total MK recovery was estimated to be less than 50%. Contaminant cells were essentially macrophages.
For MK purification by cell sorting, low-density bone marrow cells were first sterilely depleted in MK by the immunomagnetic bead technique as described above. The GP IIIa negative cells were cultured at a concentration of lo6 cells/mL in the presence of AP (10%) plus rhIL-3 (100 U/mL). At day 6 of culture cells were sterilely labeled by the indirect immunofluorescence procedure as described above and by using the Y2/51 MoAb. MK were sorted on their fluorescence intensity, volume, and wide-angle light scattering using an ATC 3000 (Bruker, Wissemburg, France) equipped with a pair of 70-pm nozzles. The positive fraction contained more than 98% MK after reanalysis with a fluorescence microscope.
Three neutralizing polyclonal antibodies against human IL-6 were tested: a goat antibody against IL-6 (a generous gift from Dr S. Poole, Hertfordshire, UK, this antibody was raised against rhIL-6 kindly provided by Drs T. Kishimoto and T. Hirano, Osaka, Japan), and two commercial rabbit antibodies against IL-6 (Genzyme, Boston, MA and Endogen, Boston, MA). rhIL-6 (a generous gift from Dr s. Clark, Genetics Institute) was also added alone in culture or to reverse the effects of the antibodies. Supernatants of the culture medium treated by antibodies against IL-6 were tested in the IL-6 bioassay to determine whether the entire IL-6 activity had been really neutralized. An IgG,, K type monoclonal anti-IL-6 antibody" (aBSF2-166, a generous gift from Dr T. Kishimoto) was used for immunochemical staining.
Immunocytochemical staining. Cytocentrifuged cultured MK were fixed in 4% paraformaldehyde (Serva, Heidelberg, Germany) in phosphate-buffered saline (PBS), pH 7.4 for 3 minutes at room temperature. Preparations were then transferred into a solution of 70% ethanol and stored at 4°C until used. The slides were washed in 0.05 mol, Tris-buffered saline (TBS) (pH 7.6) for 20 minutes, incubated with human Ig (1 g/lOO mL in TBS; Mtrieux, Lyon, France) for 30 minutes, and washed three times in TBS. The slides were incubated with a lil00 dilution of aBSF2-166 (30 pg/mL purified IgG) for 1 hour. Subsequently, the slides were washed in TBS and incubated with a 1/40 dilution of alkaline phosphataseconjugated sheep antimouse IgG (Byosis, Compikgne, France) for 30 minutes. All reactions were performed at room temperature. The slides were washed in TBS 0.1 m o l b (pH 8.2), levamisole (0.025 g/mL, Sigma), and were incubated in the substrate solution containing naphtol AS phosphate and Fast Red TR salt (Sigma) for 10 minutes. The reaction was terminated by rinsing the slides in tap water. Slides were counterstained with Mayer's hemalum solution and mounted in glycerol gelatin. Several negative controls were used, such as (1) omitting the first antibody incubation and (2) using nonrelevant IgG,, K type MoAbs at the same concentration as for aBSF2-166.
IL-6 activity in the culture supernatants was measured using an IL-6-dependent hybridoma clone (7TD1), as described by Van Snick et aI.l9 Various dilutions (the first dilution was 112) of the culture supernatants were added in triplicate to the 7TD1 cells and cultured for 4 days with or without anti-IL-6 antibody. Cell proliferation was estimated by colorimetric determination." rhIL-6 was used as an internal standard. One unit per milliliter of IL-6 was defined by the concentration corresponding to the half-maximal growth of 7TD1 cells. In our hands, the lower limit of detection of this test was 0.5 U/mL of IL-6 in the sample. When the same sample was examined several times, variability in the measure of IL-6 was about 5% to 15%.
ELISA was performed according to the manufacturer's instructions (Genzyme) on serial dilutions of either extracts from soniAntibodies against IL-6 and rhIL-6.
IL-6 bioassay and ELISA for the quantitution of IL-6.
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cated or freezing and thawing purified platelets, or U937 (negative control) or MEG-01 (positive control) conditioned media. rhIL-6 (Genzyme) was used as an internal standard. In our hands, the lower limit of detection was 0.3 ng/mL of rhIL-6 standard.
IL-6 production was quantitated in supernatants of cultures either before or after purification of MK and in platelets. IL-6 quantitation in semisolid culture was performed using the methyl cellulose culture procedure as previously described." For purification, MK were obtained by cell sorting at day 6 of culture. MK (1 x lo4 cells/mL) were cultured in 0.5 mL for 3 days in the presence of either PPP, or AP or PPP plus rhIL-3 (100 U/mL). In other experiments, MK purified by the immunomagnetic bead technique as well as the cell fraction depleted in MK were maintained 18 hours in culture at 2.5 X l@ cells/mL. Conditioned media were tested for the presence of IL-6 using a bioassay. In the two latter cases, PPP and AP used in culture were devoid of detectable IL-6 activity. Both platelet extracts and platelet products released by thrombin stimulation were studied. For thrombin stimulation, 2 x lo9 human purified platelets were suspended in 10 mL with or without human thrombin (3 U/mL, Ortho Diagnostics System, Raritan, NJ) for 10 minutes at 37°C and the supernatants were tested for the presence of IL-6 using the bioassay. Purified platelets extracts (10" platelets in 1 mL) were obtained after sonication or after five cycles of freezing and thawing. After sample centrifugation, the supematants were tested for the presence of IL-6 using the bioassay or the ELISA. The first platelet dilution tested in the bioassay and the ELISA corresponded to lo9 extracted cells.
The IL-6 probe used in these studies was a 700-bp XmnI-Ban1 insert" of human IL-6 cDNA (a generous gift from Drs C. Vaquero and J. Sanceau, Paris, France) cloned into the pGEM-4 plasmid (Promega Biotec, Madison, WI). The sequence of the recombinant pGEM-4-IL-6 was checked by the dideoxy sequencing method using denatured plasmid template. 22 The IL-6-R probe was a 900-bp SphI-NcoI insert" of human IL-6-R cDNA (a generous gift from Drs T. Kishimoto and T. Hirano) cloned into the pGEM-SZf(+) (Promega Biotec). As a positive control, a murine p-actin cDNA (a generous gift from Dr F. Dautry, Villejuif, France) cloned into a transcription vector was used. As a negative controI, a 1.37-kb A phage DNA fragment cloned into a pGEM vector was used. Another negative control probe for MK was used; it was a 560 bp of human p-globin cDNA (a generous gift from Dr P.-H. RomBo, CrCteil, France) cloned into a transcription plasmid. Using these RNA antisense probes in previous Northern blot experiments, IL-6 and IL-6-R mRNA were detectable as single bands of 1.3 and 5 kb, respectively? For dot blot RNA quantification, a human NADH dehydrogenase (NADHd)24,25 cDNA probe cloned into the pUC13 plasmid was used (a gift from Dr N. Modjtahedi, Villejuif, France).
RNA extraction, polymerase chain reaction (PCR), and dot blot analysis. Total RNA from purified platelets, purified cultured MK (GP IIIa positive), GP IIIa negative cells, adherent monocytes, and different cell lines was extracted. Cultured human MK at day 10 of culture were purified by the immunomagnetic bead technique, and total RNA from 6 x lo5 GP IIIa positive cells, 2.2 x lo6 GP IIIa negative cells, and from 1 x lo6 cells of the different cell lines was isolated by a single-step method.26 This procedure allowed us to recover 2.5, 7.6, and about 5 pg of total RNA from GP IIIa positive cells (purified MK), GP IIIa negative cells, and cell lines, respectively. Total RNA concentrations in aqueous solution were estimated from the OD at 260 nm. The integrity of samples was confirmed after electrophoresis by ethidium bromide staining of the 28s and 18s ribosomal RNA.
RNA (100 ng) was subjected to PCR analysis using, successively, a 23-mer sense and a 21-mer antisense oligonucleotide located in Molecular probes. the second and third exon of the human IL-6 gene,*' respectively. After the reverse transcription step using the antisense oligonucleotide, 30 cycles of amplification were performed as previously described." The amplification product (214 bp) was analyzed by Southern blot hybridization using a 23-mer sense internal oligonucleotide probe (12 nucleotides of the second exon and 11 nucleotides of the third exon of the human IL-6 gene) labeled using [.v"P-] dATP (3,000 Ci/mmol; Amersham, Les Ulis, France). As a control for the integrity of RNA, RNA samples from purified MK and platelets were subjected to PCR analysis using GP Iba sense and antisense oligonucleotides.
Total RNA was dot blotted to Hybond-N filters (Amersham). Runoff transcripts of linearized pGEM4-IL-6 plasmid were synthesized using T7 RNA polymerase in a reaction performed according to the manufacturer's instructions (Promega Biotec) and containing 60 pCi [a"P-] UTP (800 Ci/mmol; Amersham) to achieve synthesis of IL-6 RNA antisense probe with a specific activity of 2 x 108 cpm/Fg. NADHd probe was labeled by nick translation according to the manufacturer's instructions (Amersham).
Filters were prehybridized in 50% deionized formamide, 0.75 mol/L NaCI, 0.15 moVL Tris-HC1 (pH 8), 0.2 mol/L phosphate buffer (pH 6 4 , 10 m m o m EDTA, 0.1% sodium dodecyl sulfate (SDS), and 500 pg/mL heparin at 55°C for 3 hours, then hybridized for 18 hours at 55°C in the same buffer containing lo6 cpm/mL of the IL-6 RNA probe. Stringent washes of hybridized filters were performed in 0.1 X SSC (1 x SSC = 150 mmoVL NaCI, 15 mmol/L Na-citrate, pH 7.0), 1% SDS, and 0.1% tetra-sodium pyrophosphate at 68°C for 1 hour before autoradiography. After 7 days of exposition, filters were dehybridized, rehybridized with the NADHd probe (lo6 cpm/mL), and washed in stringent conditions as described above.
For the in situ hybridization study, runoff transcripts of appropriated linearized plasmid were synthesized using either T7, SP6, or T3 RNA polymerase in a reaction containing 60 pCi [a3'S-] UTP (1,200 Ci/mmol; Amersham) and performed according to the manufacturer's instructions (Promega Biotec), except that unlabeled UTP was omitted from the reaction medium to achieve synthesis of RNA probe with a specific activity of lo9 cpm/p,g. The fragment length of RNA probes was adjusted to a mass average of approximately 100 to 150 bases by limited alkaline hydrolysis. The RNA probes were of similar specific activity and size (determined by gel electrophoresis under denaturating conditions).
The techniques used for fixation, hybridization, and stringent washes under reducing conditions were based on works previously rep~rted,'~.~' with some modifications. The cells were cytocentrifuged and immediately fixed in 4% paraformaldehyde (Serva, Heidelberg, Germany) in PBS, pH 7.4 for 3 minutes at room temperature. Preparations were then transferred into a solution of 70% ethanol and stored at 4°C until use. At this point some negative control slides were treated with 100 pg/mL RNase A (Boehringer) and 10 U/mL RNase T1 (GIBCO BRL, Cergy Pontoise, France) in 2 x SSC for 2 hours at 37°C. The slides were postfixed in 2% paraformaldehyde/l% glutaraldehyde (Sigma) in PBS for 7 minutes, washed in PBS, acetylated in 0.25% acetic anhydride in 0. 
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salmon sperm DNA, and 10s cpm/mL of the RNA probe. The hybridization mixture was denaturated, applied to slides, and covered with parafilm. Hybridization was performed at 50°C for 18 hours in a humidified chamber. Washes were performed in the presence of reducing agents (10 mmol/L dithiothreitol, 20 mmol/L 2-mercaptoethanol) when not specified. The slides were successively washed at 54°C for 5 minutes (1) three times in 2 x SSC; (2) three times in 50% formamide, 2 x SSC; (3) three times in 2 x SSC followed by a RNase digest in absence of reducing agents (10 p,g/mL RNase A plus 10 U/mL RNase T1 in 2 x SSC) for 10 minutes at 37°C. After a second set of washing in 50% formamide, 2 X SSC at 54°C for 5 minutes, the slides were successively rinsed at 54°C for 5 minutes in (1) Kd) of the radioiodinated protein was checked by SDS-polyacrylamide gel electrophoresis analysis under reducing conditions according to the procedure of Laemmli" (data not shown). In our hands, ['2'1] rhIL-6 was shown to bind specifically to the U937 cell line, whereas no specific binding to the K562 cell line was detected? Binding assays were performed according to previous ~o r k s . )~, '~ Briefly, binding was initiated by the addition of 1 X lo6 three times-washed cells in 100 )IL of Eagle's Minimum Essential Medium (Eurobio) containing 1% bovine serum albumin and 1.5
In situ autoradiography after ['"I] rhIL-6 binding.
ng of rhIL-6 in the presence or the absence of a 200-fold excess of unlabeled rhIL-6, and the cells were shaken for 2 hours at 4°C. After incubation, the reaction mixture was centrifuged at 9,000 rpm for 3 minutes through 125 JLL of a mixture of 40% dinonyl phthalate and 60% dibutyl phthalate. The tube was cut just above the cell pellet, and specifically bound radioactivity was calculated by subtracting the radioactivity associated with cells incubated with an excess of unlabeled rhIL-6 from that of cells incubated with labeled rhIL-6 alone. The number of specific binding sites per cell for ["'I] rhIL-6 is given by: sitesicell = specifically bound radioactivity X total quantity of rhIL-6 added X Avogadro numbedtotal radioactivity added x molecular weight X number of cells. For in situ autoradiography, cells were resuspended, cytocentrifuged, fixed by methanol, and coated with NTB3 emulsion (Eastman Kodak). After 10 days of exposure, the slides were developed and fixed as described above for the in situ hybridization procedure and stained with May-Griinwald Giemsa.
A double-staining technique associated to flow cytometry was used to measure the ploidy of MK.3S Cells in the liquid culture system (at day 10 of culture) were fixed by 2% paraformaldehyde (Serva) for 20 minutes at 4°C and washed three times in PBS without calcium and magnesium (GIBCO BRL). Cells, 1 x lo6, were incubated with six different MoAbs, each one at a dilution of 1:400 at 4°C for 30 minutes. Five of these antibodies recognize determinants of the GP IIb/IIIa and the last one, GP Iba. These antibodies were precisely characterized during the Fourth International Workshop on MoAbs." After three washes, cells were incubated with fluoresceinconjugated sheep IgG directed against mouse Ig (Silenus, Hawthorn, Australia) for 30 minutes at 4°C and washed twice.
After the above described immunolabeling, cells were washed in PBS and permeabilized by 0.002% Triton X-100 (Sigma) containing 100 Kg/mL RNase A (Boehringer) in isotonic sodium citrate solution (Merck, Darmstadt, Germany) for 20 minutes. A propidium iodide (Sigma) solution at 50 Kg/mL in isotonic sodium citrate containing 100 pg/mL RNase A was used for DNA staining for 30 minutes. Cells were finally analyzed by an ATC 3000 flow cytometer (Bruker, Wissembourg, France) equipped by an argon ion laser, tuned to deliver 400 mW at 488 nm. A pair of 90-wm nozzles were applied. To separate the emission spectrum of propidium iodide and fluorescein, a dichroic (560 nm) mirror was used. Filters for red fluorescence (LP 590 nm) and green fluorescence (BP 5201510 Double-staining and flow cytometry analysis. For personal use only. on October 24, 2017. by guest www.bloodjournal.org 2,3,4 ,5,6, 7,8, and 9, respectively) was hybridizided after Southern blot using a 23-mer sense internal oligonucleotide probe deduced from the human IL-6 sequence (A). Exposure time was 4 hours. IL-6 mRNA was detectable as a single band of 214 bp (arrow). No specific hybridization was found in RNA extracted from platelets, whereas GP Iba mRNA was detected in this sample (data not shown). Total RNA (1, 0.5, and 0.25 pg, respectively, lanes a, b, and c) from GP llla positive cells, GP llla negative cells, U937 and HELVJZO cell lines (1.2.3, and 4, respectively) was dot blotted and hybridization was performed using the [UP]-labeled IL-6 RNA probe (B) and the NADHd probe after dehybridization of the filter (C). Exposure was 7 days for both probes. Fived peripheral human lymphocytes and standard polystyrene beads (Polysciences, Paris, France) were used for standard. The frequency of MK in different classes was evaluated usually on lo" MK. The ploidy distribution was determined by setting markers at the nadirs between peaks. All ploidy classes over 16N were counted together because these MK were rare in culture.
RESULTS
We first determined whether IL-6 protein could be detected in MK cultures (Table 1) . First, we sought evidence for secretion of IL-6 protein by a biologic assay and found that IL-6 (75 to 350 U/mL) was detectable in 10-day supernatants of either methyl cellulose or liquid bone marrow cultures performed in the presence of AP or PPP plus rhIL-3. In contrast, no IL-6 activity could usually be detected at the beginning of the culture (data not shown). The proliferative effect on 7TDl cells was neutralized by a polyclonal anti-IL-6 antibody, confirming that this activity represents biologically active IL-6. However, these marrow cultures contain only 10% to 30% of MK. Therefore, cultured MK were purified by the immunomagnetic bead technique, which allowed us to obtain MK (GP IIIa positive cells) with a purity of 96%. This cell fraction, as well as the remaining (GP IIIa negative) cells, were cultured at the same cell concentration (2.5 X lo5 cells/mL) for 18 hours in a culture medium devoid of detectable IL-6 activity. IL-6 activity, neutralizable by an anti-IL-6 antibody, was found in both cell populations in two independent experiments at concentrations of 65 and 115 U/mL (mean of triplicate of two independent experiments) in the GP IIIa positive and negative cells, respectively. Because only 4% non-MK cells were present in the GP IIIa positive cells, we can exclude the possibility that this IL-6 activity only derives from contaminant cells. The GP IIIa negative cell population was mainly composed of CFU-GM-derived macrophages. Our results show that they synthesize much less IL-6 than activated blood monocytes." Finally, MK were purified nearly to homogeneity (purity higher than 98%) by cell sorting at day 6 of culture. MK (1 x lo4 cells/mL) were subsequently cultured for 3 days in the presence of either PPP or AP, or PPP plus IL-3. These culture media were devoid of detectable IL-6 activity. In all these culture IL-6 expression in human normal MK Y . . .
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For personal use only. on October 24, 2017. by guest www.bloodjournal.org From conditions IL-6 was biologically detected at concentrations of 12, 16, and 14 U h L , respectively. In contrast, IL-6 was not detected by bioassay nor by ELISA in purified platelet extracts or in products from thrombin-activated purified platelets (data not shown).
The purification of MK by the immunomagnetic bead technique also allowed us to study IL-6 transcripts. IL-6 transcripts were first analyzed by the PCR technique ( Fig  1A) and were detected in the GP IIIa positive and negative cells as well as in K562, MEG-01 cell lines, and adherent monocytes. In contrast, IL-6 transcripts were detected neither in negative controls such as U937 and HELVJ20 cell lines as previously described'.'' nor in RNA from purified platelets, whereas GP Iba mRNA was detectable in RNA from platelets as well as from GP IIIa positive cells (data not shown). Thc contribution of the 4% contaminant GP IIIa negative cell population in the detection of IL-6 mRNA was studied by the mixture of total RNA from U937 cells (negative for IL-6) with 4% of total RNA extracted from GP IIIa negative cultured bone marrow cells. Whereas a 4-hour exposure time of the blotted and hybridized PCR products was sufficient to detect the IL-6 transcripts in the GP IIIa positive cell fraction, no specific hybridization was found for this exposure time with the artificial mixture of RNA (Fig 1A) . However, a faint hybridization signal was found after a longer exposure time (data not shown). Nevertheless, by semi-quantitative PCR procedure we were unable to totally exclude the possibility that the contaminant GP IIIa negative cell population was not responsible for the detected signal in the GP IIIa positive cells. IL-6 mRNA was also detccted by a simple dot blot analysis in the GP IIIa positive and negative cell populations (Fig 1, B and  C) , suggesting that IL-6 mRNA levels were sufficient to determine at the unicellular level the origin of its production.
We performed in situ hybridization using several labeled RNA probes. In preliminary experiments, as ["SI-RNA probes were found to give high background in MK, we used ["PI-RNA probes, which were found to give a better ratio specific signalbackground (data not shown). As this result suggested a covalent binding of [%]-RNA probes to MK molecules (probably to thiosulfate macromolecules), we therefore performed in situ hybridization using increasing concentration of reducing agents such as dithiothreitol and 2-mercaptoethanol.
By using in situ hybridization with ["SI-RNA probes under higher reducing conditions, we observed that macrophages but also more than 30% of the cultured MK were significantly labeled using the IL-6 probe, in comparison with negative controls such as P-globin and h-probes (Figs 2  and 3) . The specificity of hybridization was also ascertained by the disappearance of the signal on ribonuclease pretreated slides (data not shown). The specific hybridization predominated in immature MK identified by their size and morphology. A lower specific labeling was observed in the more mature MK.
IL-6 protein was further detected at the unicellular lcvel by an immunoalkaline phosphatase technique using an MoAb against IL-6. As shown in Fig 4, an intense diffuse intracytoplasmic staining was demonstrable in the small immature MK whereas a peripheral staining was found in 
80
Relative frequency large immature MK. No specific staining was detectable in the more mature MK. This staining was not granular, suggesting that IL-6 protein in MK is not stored in a-granulcs. Macrophages showed a diffuse staining.
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From (Fig 5) , whereas no binding was found when the cells were incubated with ['251] rhIL-6 in the presence of a 200-fold excess of unlabeled rhIL-6. Macrophages were also shown to express IL-6-R but with a much lower intensity than MK (data not shown).
Effects of IL-6 endogenous production on proliferation and endoreplication of MK. Finally, we tested whether this endogenous production of IL-6 may play a role in the proliferation and endoreplication of MK.
First, MK were grown in suspension culture in the presence of normal plasma or AP. The endogenously produced IL-6 was neutralized by adding each polyclonal antibody at the beginning of the culture and every 2 days to neutralize 500 U/mL of IL-6. The neutralization was checked by the 7TD1 bioassay. Only one of the three antibodies (the goat anti-IL-6 antibody) was able to totally neutralize the IL-6 present in the culture supernatant, probably because of a sufficient affinity for IL-6. This neutralization leads to a significant decrease in the number of MK (50% in two independent experiments) in the presence of either PPP or AP (Figs 7 and 8 ). The effect of the antibody could be reversed by the addition of rhIL-6 in excess. In contrast, the two other antibodies that partially neutralize IL-6 had no effect on the MK proliferation (data not shown).
The effect of this neutralization was also tested on the MK ploidy. In culture stimulated by AP, a slight effect on MK ploidy was observed since the anti-IL-6 antibody decreased the absolute number of MK with a higher ploidy than 8N, more than of those belonging to the 2N, 4N, and 8N ploidy classes (Fig 8C) . This effect was also reversed by rhIL-6 addition. With PPP, the effect was more difficult to appreciate because the number of MK with a ploidy higher than 8N was extremely low. Second, antibodies against IL-6 were also added at the beginning of the culture and every 2 days in semisolid culture assays. No significant decrease in the number of colonies was observed in culture stimulated by normal plasma or by AS, whereas a significant decrease (42%) in the colony number was observed in those stimulated by IL-3 (Table 2 ).
DISCUSSION
In this study, we have first shown by several lines of evidence that cultured normal MK produce biologically active IL-6 and contain IL-6 protein.
The presence of the IL-6 protein in MK could be the result of an endocytosis, because several other platelet proteins such as albumin or Igs are not synthesized by MK.% However, IL-6 transcripts were detected in cultured MK by the PCR technique performed on purified cultured MK population and also by in situ hybridization, indicating that IL-6 is actively synthesized by MK rather than being acquired from its environment. IL-6 expression appears to be inversely correlated to the MK maturation stages because hybridization predominates in immature MK and no IL-6 (biologic activity, antigen, and mRNA) is detectable in normal platelets. We subsequently investigated the presence of an IL-6-R to show whether an autocrine loop by IL-6 could occur in MK. We could detect IL-6-R transcripts by in situ hybridization as well as the IL-6-R protein by binding experiments. Some previous observations have already indicated that human megakaryocytopoiesis may be controlled by autocrine regulators such as transforming growth factor and platelet factor 4."' Our results show that all components for an IL-6 autocrine loop are present in human cultured MK.
Recently, we have observed that IL-6 and IL-6-R are expressed in cell lines with erythroid/MK features: and that in one of them IL-6 is an autocrine factor involved in the regulation of its terminal differentiati~n.~' The present study suggests that the expression of IL-6 and IL-6-R in these leukemic cell lines is a reflection of normal physiol-
om.
Finally, we tested the function of the endogenous production of IL-6 on MK ploidy and proliferation. In the mouse the effect of IL-6 on megakaryocytopoiesis has been well demonstrated, because the addition of IL-6 favors MK maturation in vitro6 and increases platelet production in vivo.' However, the precise function of IL-6 on human megakaryocytopoiesis remains controversial. For most investigators, it has neither MK colony-stimulating activity nor MK-potentiating activity," whereas others have detected one or both of these activities:' The present report suggests that the effect of exogenous IL-6 on in vitro human assays may be masked by an endogenous production of IL-6. Therefore, we tried to neutralize the IL-6 produced in culture with antibodies. In suspension liquid cultures, this neutralization had two effects that could be entirely reversed by rhIL-6: (1) a decrease in the number of MK and (2) a slight shift in the ploidy distribution toward lower values. This last result extends to the human species the results Ishibashi et al"' had in the mouse, which shows that IL-6 is a late regulator of megakaryocytopoiesis. Conversely, the decrease in the number of MK after IL-6 neutralization could also mean that IL-6 is an MK-CSF. However, in semisolid medium assays the addition of IL-6 Bone marrow low-density cells were cultured in a semisolid medium using the plasma clot technique in the presence of either AS or PPP plus rhlL-3 (100 U/mL). In some samples, rabbit antibody against IL-6 (at a concentration to neutralize 100 U/mL) was added at the beginning of the culture and every 2 days. The control was an irrelevant rabbit antiserum at the same concentration. rhlL-6 (1,000 U/mL) was added at the beginning of the culture. AS, PPP, as well as citrated bovine plasma used in these cultures were devoid of any detectable IL-6 activity. Cultures were incubated for 12 days at 37°C in duplicate.
did not allow us to grow MK colonies (data not shown). Furthermore, neutralization with antibodies of the endogenously produced IL-6 did not abrogate MK colony formation in the absence of added growth factor, AP, or IL-3. Only in this last condition of stimulation was a decrease in colony number observed. These results further confirm that IL-6 is not an MK-CSF but may potentiate the MK-CSF activity of IL-3. Its effect on the MK number in culture may be related to a proliferative effect on promegakaryoblast and not on CFU-MK. Alternatively, IL-6 might be a survival factor for MK. In addition, these results show that, in contrast to the murine species, the MK-CSF activity of IL-3 is not entirely mediated by IL-6.42 However, we cannot exclude the hypothesis suggested by Lotem et a142 and Sachs4' that IL-6 is an autocrine-differentiating factor synthesized by several hematopoietic cell lines including MK as a second messenger of other growth factors. Indeed, the effect of IL-6 may be partially mediated intracellularly, and therefore the use of neutralizing antibodies may be inadequate.
Hence, further experiments on homogenous populations of MK precursors are required to understand the precise role of the endogenous production of IL-6 and the mechanisms that regulate its synthesis.
